Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract.

Standard

Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract. / Eiber, Matthias; Oers, van; Johanna, M M; Zwarthoff, Ellen C; Kwast, van der; Theo, H; Ulrich, Oehler; Helpap, Burkhard; Stoerkel, Stephan; Sauter, Guido; Cheville, John; Sauter, Guido; Wild, Peter J; Stoehr, Robert; Hofstaedter, Ferdinand; Hartmann, Arndt.

in: AM J SURG PATHOL, Jahrgang 31, Nr. 6, 6, 2007, S. 938-946.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Eiber, M, Oers, V, Johanna, MM, Zwarthoff, EC, Kwast, VD, Theo, H, Ulrich, O, Helpap, B, Stoerkel, S, Sauter, G, Cheville, J, Sauter, G, Wild, PJ, Stoehr, R, Hofstaedter, F & Hartmann, A 2007, 'Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract.', AM J SURG PATHOL, Jg. 31, Nr. 6, 6, S. 938-946. <http://www.ncbi.nlm.nih.gov/pubmed/17527084?dopt=Citation>

APA

Eiber, M., Oers, V., Johanna, M. M., Zwarthoff, E. C., Kwast, V. D., Theo, H., Ulrich, O., Helpap, B., Stoerkel, S., Sauter, G., Cheville, J., Sauter, G., Wild, P. J., Stoehr, R., Hofstaedter, F., & Hartmann, A. (2007). Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract. AM J SURG PATHOL, 31(6), 938-946. [6]. http://www.ncbi.nlm.nih.gov/pubmed/17527084?dopt=Citation

Vancouver

Eiber M, Oers V, Johanna MM, Zwarthoff EC, Kwast VD, Theo H et al. Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract. AM J SURG PATHOL. 2007;31(6):938-946. 6.

Bibtex

@article{1270178ea08448abb8a181b36896d818,
title = "Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract.",
abstract = "AIM: Inverted papilloma (IP) of the urinary tract can be difficult to distinguish from noninvasive urothelial carcinoma with prominent inverted growth pattern (invNIUC). Ancillary markers may help to resolve such cases and clarify the reported malignant potential of some IPs. METHODS: Eighty-nine urothelial lesions initially diagnosed as IP were reviewed by 4 experienced urologic pathologists and studied immunohistochemically (Ki67, p53, CK20, MSH2, MLH1, and MSH6). Mutations of the FGFR3 gene, deletions (loss of heterozygosity) of 9p, 9q, and 17p, microsatellite instability, and elevated microsatellite instability at selected tetranucleotides were also analyzed. RESULTS: Considerable interobserver variability in histopathologic diagnoses was noticed. Only 62 (69.7%) initial diagnoses were confirmed by the review pathologists whereas 23 tumors (25.8%) were redefined as invNIUC. Molecular analyses revealed infrequent alterations in IPs, including microsatellite instability (1.8%), elevated microsatellite instability at selected tetranucleotides (13.2%), FGFR3 mutations (9.8%), 9p deletions (3.9%), 9q deletions (13.2%), 17p deletions (5.1%), nuclear p53 accumulation (18.9%), and aberrant immunostaining for MSH2 (5.8%), MLH1 (11.8%), and MSH6 (3.8%). IP and invNIUC differed in FGFR3 mutations and Ki-67 labeling index (P",
author = "Matthias Eiber and van Oers and Johanna, {M M} and Zwarthoff, {Ellen C} and Kwast, {van der} and H Theo and Oehler Ulrich and Burkhard Helpap and Stephan Stoerkel and Guido Sauter and John Cheville and Guido Sauter and Wild, {Peter J} and Robert Stoehr and Ferdinand Hofstaedter and Arndt Hartmann",
year = "2007",
language = "Deutsch",
volume = "31",
pages = "938--946",
journal = "AM J SURG PATHOL",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

RIS

TY - JOUR

T1 - Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract.

AU - Eiber, Matthias

AU - Oers, van

AU - Johanna, M M

AU - Zwarthoff, Ellen C

AU - Kwast, van der

AU - Theo, H

AU - Ulrich, Oehler

AU - Helpap, Burkhard

AU - Stoerkel, Stephan

AU - Sauter, Guido

AU - Cheville, John

AU - Sauter, Guido

AU - Wild, Peter J

AU - Stoehr, Robert

AU - Hofstaedter, Ferdinand

AU - Hartmann, Arndt

PY - 2007

Y1 - 2007

N2 - AIM: Inverted papilloma (IP) of the urinary tract can be difficult to distinguish from noninvasive urothelial carcinoma with prominent inverted growth pattern (invNIUC). Ancillary markers may help to resolve such cases and clarify the reported malignant potential of some IPs. METHODS: Eighty-nine urothelial lesions initially diagnosed as IP were reviewed by 4 experienced urologic pathologists and studied immunohistochemically (Ki67, p53, CK20, MSH2, MLH1, and MSH6). Mutations of the FGFR3 gene, deletions (loss of heterozygosity) of 9p, 9q, and 17p, microsatellite instability, and elevated microsatellite instability at selected tetranucleotides were also analyzed. RESULTS: Considerable interobserver variability in histopathologic diagnoses was noticed. Only 62 (69.7%) initial diagnoses were confirmed by the review pathologists whereas 23 tumors (25.8%) were redefined as invNIUC. Molecular analyses revealed infrequent alterations in IPs, including microsatellite instability (1.8%), elevated microsatellite instability at selected tetranucleotides (13.2%), FGFR3 mutations (9.8%), 9p deletions (3.9%), 9q deletions (13.2%), 17p deletions (5.1%), nuclear p53 accumulation (18.9%), and aberrant immunostaining for MSH2 (5.8%), MLH1 (11.8%), and MSH6 (3.8%). IP and invNIUC differed in FGFR3 mutations and Ki-67 labeling index (P

AB - AIM: Inverted papilloma (IP) of the urinary tract can be difficult to distinguish from noninvasive urothelial carcinoma with prominent inverted growth pattern (invNIUC). Ancillary markers may help to resolve such cases and clarify the reported malignant potential of some IPs. METHODS: Eighty-nine urothelial lesions initially diagnosed as IP were reviewed by 4 experienced urologic pathologists and studied immunohistochemically (Ki67, p53, CK20, MSH2, MLH1, and MSH6). Mutations of the FGFR3 gene, deletions (loss of heterozygosity) of 9p, 9q, and 17p, microsatellite instability, and elevated microsatellite instability at selected tetranucleotides were also analyzed. RESULTS: Considerable interobserver variability in histopathologic diagnoses was noticed. Only 62 (69.7%) initial diagnoses were confirmed by the review pathologists whereas 23 tumors (25.8%) were redefined as invNIUC. Molecular analyses revealed infrequent alterations in IPs, including microsatellite instability (1.8%), elevated microsatellite instability at selected tetranucleotides (13.2%), FGFR3 mutations (9.8%), 9p deletions (3.9%), 9q deletions (13.2%), 17p deletions (5.1%), nuclear p53 accumulation (18.9%), and aberrant immunostaining for MSH2 (5.8%), MLH1 (11.8%), and MSH6 (3.8%). IP and invNIUC differed in FGFR3 mutations and Ki-67 labeling index (P

M3 - SCORING: Zeitschriftenaufsatz

VL - 31

SP - 938

EP - 946

JO - AM J SURG PATHOL

JF - AM J SURG PATHOL

SN - 0147-5185

IS - 6

M1 - 6

ER -